Post-transplantation-emerging anti-HLA DQA1/DQB1 antibody possibly responsible for graft rejection after myeloablative-unrelated marrow grafting

Bone Marrow Transplant. 2016 Apr;51(4):601-3. doi: 10.1038/bmt.2015.292. Epub 2015 Dec 7.

Authors

H Yabe¹, T Morimoto², H Takakura², M Okuya³, R Ikegaya², S Kato¹, T Sugimoto⁴, F Tsuchida⁴, M Murakami⁴, H Mochizuki², M Yabe¹

Affiliations

¹ Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan.
² Department of Pediatrics, Tokai University School of Medicine, Isehara, Japan.
³ Department of Pediatrics, Dokkyo Medical University School of Medicine, Tochigi, Japan.
⁴ Division of Medical Technology, Tokai University Hospital, Isehara, Japan.

PMID: 26642341
DOI: 10.1038/bmt.2015.292

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Allografts
Bone Marrow Transplantation*
Child, Preschool
Graft Rejection / blood*
HLA-DQ alpha-Chains*
HLA-DQ beta-Chains*
Humans
Isoantibodies / blood*
Male
Mucopolysaccharidosis II / blood*
Mucopolysaccharidosis II / therapy*

Substances

HLA-DQ alpha-Chains
HLA-DQ beta-Chains
HLA-DQA1 antigen
HLA-DQB1 antigen
Isoantibodies